MAPT and dementia: In Alzheimer's disease (AD), these are primarily different amyloid β (Aβ) peptides and a hyperphosphorylated form of the tau protein [51], whereas α-synuclein is implicated in Parkinson's disease, dementia with Lewi bodies and other forms of dementia [52,53].